compounds, at least monocyclic, to yield nitro anion radicals and have been invaluable in extending work from animal and superoxide (31) . P450s are involved in the oxygenation models to humans. reactions but a number of redox-active enzymes can participate Characterization of roles of individual enzymes in carcinogen in activation (and detoxification) of nitro groups via reducmetabolism tion (32, 33) .
By 1980 many of the general concepts about the significance Oxidation of polycyclic hydrocarbon diols of enzymes in carcinogen metabolism had been developed, at One transformation that was not recognized until the 1980s was least in principle. For instance, enzymes such as P450 were the oxidation of trans-dihydrodiols of aromatic hydrocarbons to known to be inducible (49), enzymatic differences could be o-catechols by dihydrodiol dehydrogenase [EC 1.3.1.20] (34) .
used to explain variable susceptibility of individual animals to These enzymes are members of an aldo-keto reductase supercarcinogens (50), and some evidence for P450 polymorphism family and also have activities toward hydroxy steroids. The as a risk factor in lung cancer had been presented (51). oxidation suppresses the formation of carcinogenic dihydrodiol Enzymology had been used successfully to address issues epoxides; conversely, the catechols may oxidize (enzymatically regarding the existence of multiple enzyme forms within some or non-enzymatically) to o-quinones and cause damage by multi-gene families (52) (53) (54) (55) (56) . reaction with macromolecules or through generation of reactive Protein chemistry and, later, molecular biology techniques oxygen species (35, 36) .
were developed to characterize the enzymes involved in Vinyl halides carcinogen metabolism, both in terms of the enzymology and In 1980 the metabolism of vinyl halides was understood also regulation of gene expression. This work was done only in terms of epoxidation. Studies in this laboratory with with experimental animal models and, most importantly, with trichloroethylene (37) and vinylidene chloride (38) established humans. Today there is a reasonably good understanding stepwise oxidation and 1,2-shifts as an explanation for the of many individual enzymes (e.g. individual P450s, GSH products. This mechanism, with hydride migration, is generally transferases, etc.) in terms of their concentrations in various viewed as a part of the oxidation of terminal olefins (with human tissues, the extent of variability among humans, and an aldehyde product) (39, 40) . Reactive haloacyl halides are the involvement of these enzymes in particular steps in produced (41) ; the relevance of these and the epoxides themmetabolism of chemical carcinogens (57). The approaches selves to genotoxicity remains to be established.
are used rather routinely and many have been relatively straightforward, although the overall significance of a particular Dihaloalkanes reaction to tumorigenesis may not always be clear. In the past In 1978 Rannug reported the GSH-dependent activation of few years, animals in which particular enzymes have been 1,2-dichloroethane (11). This pathway is now well-established, 'knocked out' have been used in cancer studies to define the with an episulfonium ion intermediate (42) and several characroles of individual proteins in the overall processes of toxicity terized DNA adducts (43) . The general pathway has been and carcinogenesis (58, 59 ). extended to dihalomethanes, although very limited information
Inter-individual variation in the enzymes involved in carcinois available about DNA adducts (44). The same pathway gen metabolism is now extensively studied. To date there has appears to apply to trihalomethanes (45).
been impressive success in the application of information Development of analytical methods about human P450s in the development of new drugs in the Although many of the basic methods existed in 1980, the past pharmaceutical industry (57). There is optimism that such two decades have seen an explosion of capability in two approaches will also be productive in the prediction of cancer major areas.
risks due to inter-individual variations in enzymes. The National Institute of Environmental Health Sciences has begun Analytical chemistry an Environmental Genome Project, in which the long-term The first area involves chromatography and spectroscopy.
goal is to associate risks with polymorphisms of the genes HPLC has been developed as a necessary technique in the area.
involved in carcinogen metabolism, as well as others (60).
Capillary electrophoresis and other new separation techniques
The overall appreciation, characterization and organization of have potential. NMR and mass spectrometry were already very information about individual genes has developed dramatically important in 1980 but today both methods have much greater since 1980. resolution and sensitivity and are coupled on-line with HPLC. Other spectroscopic methods such as fluorescence (46) have Development of approaches to chemoprevention been applied to DNA adduct studies. 32 P-post-labeling was Chemoprevention is discussed in another article in this issue developed as a method of DNA adduct analysis by Randerath (61) . The strategy of inducing 'Phase II' conjugating enzymes (47) and has been integrated into metabolic studies, although was already in place before 1980 (62), but knowledge about this method may ultimately be replaced by mass spectrometry the regulation of conjugating enzymes (63) and the inhibition methods.
of P450s (64-66) has been integrated. Also of interest, however, Recombinant DNA technology are reports that some of the chemopreventive agents can These approaches were in their infancy in 1980. In 1982 increase the toxicity, or at least DNA adduct formation, by the first P450 cDNA sequence was published (48), and the inducing the conjugating enzymes (67, 68) . characterization of the enzymes involved in carcinogen metaDevelopment of in vitro genotoxicity assays bolism would have been impossible without these methods.
These cellular systems are very useful both in basic studies Scarce proteins can be identified, characterized, and produced on roles of enzymes in activation/detoxification and in practical in large amounts.
work on new chemicals, etc. The majority of the major systems As an aside, it should be emphasized that human tissue samples are now much more readily available than in 1980 used today was done before 1980. During the past decade many improvements in the systems have been made, particularly in be understood about most of the enzymes under consideration terms of integration with enzyme systems of mammalian origin.
here (for recent review on the enzymes of interest, see ref. Purified enzymes and human microsomes have been added 86). The questions relate to both structure and catalysis (which to Salmonella typhimurium-based systems, both in the classic are not unrelated). With some of the enzymes, the availability Ames' reversion assay (69) and an SOS response-based coloriof crystal structures has facilitated progress (87,88); more are metric assay (70) , in order to define roles of individual needed. Enzymology issues with practical implications include enzymes. Another approach is to express individual enzymes, the question of whether P450s can catalyze 1-electron oxidation or sets of enzymes, and reporter genes within cells. Such of polycyclic aromatic hydrocarbons (82) . This hypothesis approaches have been utilized with mammalian cells (71) and seems reasonable but has been difficult to address (89). The bacteria (72) . Both S.typhimurium and Escherichia coli-based meaning of K m in most of the enzymatic transformations is systems with P450s have been used (73) (74) (75) .
not well understood (90) (91) (92) ; what does this value mean when incorporated into PBPK models (93)? Development of predictions for humans based upon species comparisons Genomics One of the problems with in vitro results obtained in some of
Genomics is a popular field today, and in the area of carcinogen the systems described above is that the relevance of metabolism metabolism there is much anticipation that genetic differences in different tissues may be difficult to relate to in vivo problems, in the enzymes of interest will be associated with major e.g. cancer. One approach is the use of PBPK models, which differences in cancer risk. Two major issues must be addressed have been developed mainly in the past 20 years. A common in the course of a massive study. The first is the identification strategy is to: (i) define specific enzymatic steps of major of the major allelic variants of the genes (that code for the relevance to bioactivation and detoxification; (ii) identify the enzymes under consideration). This effort will require largemost important tissues, in terms of metabolism and as targets scale sequencing efforts. In some enzyme families not all of for tumor development; (iii) collect data on rates of all relevant the individual genes have been identified yet (94,95). enzymatic transformations in vitro, with tissues of interest
The second issue is functional analysis. One approach to both from humans and experiment models; (iv) if possible (i.e.
assessing the significance of genetic variations is to go directly with reasonably weak cancer suspects such as industrial to epidemiological correlations. However, the danger of going solvents), validate the model in humans with low exposures; directly to such associations in the absence of basic scientific and (v) on the basis of comparisons and predictions about the information has been demonstrated in the work with P450 effective concentration of the activated carcinogen delivered 2D6 (96,97). A logical approach is development of functional at the target site in humans and animals, compare the risk of analysis systems, in which allelic variants of enzymes can be concentrations of the chemical to humans to those known to expressed and examined for parameters relevant to metabolism produce tumors in the experimental animal models (76, 77 In a sense, most of the progress made in the regulation of the upwards.
enzymes of interest has been made in the past 20 years, primarily because of the development of useful methodology.
Current and future issues in metabolism of chemical carci-
Today, much is known about the systems, but even more nogens questions remain. In many cases, even the primary responsive Although much progress has been made in the past 20 years elements (receptors) remain to be identified and fully characterand the field has matured, there are a number of remaining ized [e.g. antioxidant response element system (98-100)]. challenges that must be considered. These involve the general Recent progress in the characterization of barbiturate and significance of the field and the basis for development of other drug-binding receptors has been promising (101,102). related areas, such as genomics.
However, as work has proceeded with the elucidation of Relevant pathways need to be established for more chemicals elements involved in gene regulation, so has the appreciation Despite all of the knowledge of pathways obtained in the past of the complexity of the systems. As an example, consider half-century or more (79), the reactions remain to be established the Ah locus. The Ah receptor has now been extensively in many cases. Some notable examples include the GSH characterized but the list of involved partners continues to conjugation of trihalomethanes found in drinking water (45) grow (103) (104) (105) (106) (107) and definition of the role of each component and the oxidation products of trichloroethylene, at least those remains challenging. that are involved in reactions with macromolecules (9) [a A need exists for more understanding of mechanisms of separate issue is the contribution of an alternate, GSH-dependregulation of enzymes involved in carcinogen metabolism. Just ent pathway to activation (80,81)]. Even after many years of as important is an understanding of the influence of modulation research on polycyclic hydrocarbons, controversies exist about on carcinogenesis and toxicity. For instance, we are still not the contribution of a radical pathway (82, 83) and suggestions in a position to provide an explanation for the carcinogenicity of 'poly' oxidized products have been proposed (84 (112) .
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better technology for high-throughput screening and also 'functional genomics' (i.e. approaches to determining the effect References of a genetic change on the enzymatic or other function of the tissue localization is a problem in that it shifts the field to be interpreted in terms of any dramatic experimental differences (126,127). One of the major problems in doing epidemiology
